Know Cancer

or
forgot password

National Wilm's Tumor Study Late Effects


N/A
18 Years
85 Years
Open (Enrolling)
Both
Wilm's Tumor

Thank you

Trial Information

National Wilm's Tumor Study Late Effects


The Late Effects Study is being conducted in order to answer scientific questions and to
serve as a resource for Wilms tumor patients and their families. Although most people in
this study enjoy good health, some may be at risk for certain health conditions. We are
collecting information from as many participants as possible in order to determine if they
or their offspring are at risk for adverse medical conditions. If there is more than one
case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate
heritability and recurrence risks.


Inclusion Criteria:



Previously enrolled in NWTS 5.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions.

Outcome Time Frame:

1 year after closure of study

Safety Issue:

No

Principal Investigator

Howard Katzenstein, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Children's Healthcare of Atlanta

Authority:

United States: Food and Drug Administration

Study ID:

199-96

NCT ID:

NCT00228696

Start Date:

September 2005

Completion Date:

December 2011

Related Keywords:

  • Wilm's Tumor
  • late effects
  • Wilms Tumor

Name

Location

Children's Healthcare of AtlantaAtlanta, Georgia  30342